TARA Biosystems
Innovating predictive cardiac physiology. For better health and longer life.
About TARA Biosystems
TARA is dedicated to pioneering predictive cardiac tissue models that enable faster, safer, and more reliable development of new medicines. Safer and more effective new medicines that rapidly make it to market means better health and longer life, and we believe that's great for people everywhere.
TARA is focused on three critical areas.
Cardiac Toxicology:
TARA's predictive tissue-based cardiac model behaves like a human heart muscle. This means that when it is employed in drug testing it can reliably identify cardiovascular complications where cell culture and animal testing models cannot; leading to a faster, safer, and less costly development process.
Precision Cardiology:
Every person is different and each person's biology contains information particular only to them. TARA's platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.
Heart Failure Drug Discovery:
Heart failure remains a leading cause of death throughout the world. TARA's platform generates physiologically accurate diseased human tissue from stem cells; allowing for reliable testing of medicines created to treat specific heart conditions.
- Founding: 2014
- Focus : Service
- Employees: 11-50
- Industry : Pharma